The Limited Times

Now you can see non-English news...

Hope: caution in the white zone. AstraZeneca only for over 60s

2021-06-13T19:51:19.323Z


Second Comirnaty or Moderna dose at 8-12 weeks (ANSA) "From Monday over 40 million Italians will be in the 'white zone'. Italy currently has one of the best European data on incidence. It is an encouraging result that allows us to look forward with more confidence. We must insist on this path. with prudence and graduality. Today more than ever it is necessary to keep the correct habits in order not to frustrate the many sacrifices made ". These are t


"From Monday over 40 million Italians will be in the 'white zone'. Italy currently has one of the best European data on incidence. It is an encouraging result that allows us to look forward with more confidence. We must insist on this path. with prudence and graduality. Today more than ever it is necessary to keep the correct habits in order not to frustrate the many sacrifices made ".

These are the words of the Minister of Health, Roberto Speranza, on the sidelines of a meeting at the Ministry on the subject of strengthening local health.

In the meantime, the Ministry of Health issued the 'Update' circular of the CTS opinion on vaccines.

The circular, signed by the director of Prevention of the ministry Gianni Rezza, indicates that the Vaxzevria vaccine by AstraZeneca "is administered only to people aged 60 or over (full cycle)".

For people who have received the first dose of this vaccine and are under 60 years of age, it reads, "the cycle must be completed with a second dose of mRNA vaccine (Comirnaty or Moderna), to be administered at a distance 8-12 weeks from the first dose ".

There are about 900 thousand Italians under 60 who have had the first dose of vaccine with Astrazeneca and now they will have to carry out the booster with Pfizer or Moderna. The recalls, as has been clarified in the circular of the ministry of health, will be made respecting the time frame initially foreseen for Astrazeneca, therefore 8-12 weeks after the first dose.

The Janssen (Johnson & Johnson) single-dose vaccine "is recommended, also in the light of what is defined by the Aifa Technical Scientific Commission, for subjects over the age of 60. If specific situations arise in which the advantageous conditions of the single administration and in the absence of other options, the Janssen vaccine should preferentially be used, subject to the opinion of the territorially competent Ethics Committee ". This is evidenced by the minutes of the Scientific Technical Committee of 11 June, attached to the circular of the Ministry of Health Updating the CTS opinion on vaccines.  


While taking into account the similarities between the AstraZeneca vaccine and the Janssen (J&J) vaccine, both for the platforms used and the type of thromboembolic events reported, "the current state of knowledge (which suggests a risk associated with adenovirus) , the number of just over one million doses administered in the country and the rarity of reports of rare thrombotic events currently available, do not allow us to draw conclusive assessments with respect to the benefit / risk ratio of the Janssen vaccine ".



 The Technical Scientific Committee (Cts) "recommends that the Regions, whenever they promote Open Day events that raise awareness of anti-SARS-CoV-2 vaccination, respect the indications for age groups, making the approach to vaccination as homogeneous as possible on the territory national".

Source: ansa

All life articles on 2021-06-13

You may like

Sports 2024-02-22T05:02:39.324Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.